NJ can regain leadership in pharma by offering modern lab spaces for biotech and other lab-based growth companies.
William Kimmerle
Advertisement
Articles by William Kimmerle
Advertisement
Latest Updated Articles
Building Pharma and Lab Spaces in New Jersey 2021–Adapting to Changing NeedsPublished: March 24th 2021 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly’s Jaypirca Achieves Primary Endpoint in Head-to-Head Phase III Study Against Imbruvica Treating CLL/SLL
2
Relation Therapeutics Forms $1.7 Billion Multi-Program Collaboration with Novartis Advancing Therapeutics for Atopic Diseases
3
Is FDA Streamlining Regulations in the Biosimilar Space?
4
Pfizer Enters Exclusive Collaboration and License Agreement with Yao Pharma for Oral Small-Molecule GLP-1 Agonists
5
